Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)
Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%
Phibro Animal Health operating margin
Operating margin is operating income as a percentage of revenue.
Phibro Animal Health's operating margin for the twelve months ending Jun 30, 2026 was 12.8%. For fiscal 2026 it was 12.8%, against 8.5% the year before. The highest annual figure on record is 12.8% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 12.8% | +4.3 |
| FY2025 | Jun 30, 2025 | 8.5% | +3.3 |
| FY2024 | Jun 30, 2024 | 5.2% | −2.1 |
| FY2023 | Jun 30, 2023 | 7.3% | −1.0 |
| FY2022 | Jun 30, 2022 | 8.4% | −0.6 |
| FY2021 | Jun 30, 2021 | 9.0% | +0.3 |
| FY2020 | Jun 30, 2020 | 8.6% | −1.4 |
| FY2019 | Jun 30, 2019 | 10.1% | −2.0 |
| FY2018 | Jun 30, 2018 | 12.1% | −0.7 |
| FY2017 | Jun 30, 2017 | 12.8% | +1.4 |
| FY2016 | Jun 30, 2016 | 11.4% | −0.3 |
| FY2015 | Jun 30, 2015 | 11.7% | +2.5 |
| FY2014 | Jun 30, 2014 | 9.2% | +0.5 |
| FY2013 | Jun 30, 2013 | 8.7% | +1.1 |
| FY2012 | Jun 30, 2012 | 7.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 12.1% | +3.2 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 11.6% | +2.0 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 13.5% | +5.2 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 14.1% | +7.3 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 8.9% | +2.2 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 9.6% | +2.1 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 8.3% | +2.0 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 6.8% | +7.1 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 6.7% | −2.6 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 7.6% | +0.0 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | 6.3% | −0.2 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -0.3% | −6.2 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 9.3% | +0.4 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 7.6% | −0.5 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | 6.5% | −3.1 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | 5.9% | −0.9 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | 9.0% | +0.3 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | 8.0% | −1.5 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | 9.6% | −0.1 |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | 6.8% | −1.2 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 8.7% | −1.1 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 9.5% | −0.6 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 9.6% | +0.5 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 8.0% | +2.7 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 9.7% | +3.8 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 10.1% | −0.9 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 9.2% | −2.6 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 5.3% | −6.1 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 5.9% | −6.4 |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 11.0% | −1.7 |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 11.8% | +0.2 |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 11.4% | −0.2 |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 12.3% | +0.3 |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 12.7% | −3.1 |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 11.6% | −0.2 |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 11.6% | −0.0 |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 12.1% | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 15.8% | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 11.8% | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | 11.6% | – |
See a number that looks wrong?